---
tags: [course]
ctime: "2024-04-17T23:06:23"
mstime: "2024-04-17T23:06:23"

level: undergraduate
subject: 
university: mit
completion: closed
percentage: 0
prereq: "( <ðŸŽ“Universities/MIT/7.06 Cell Biology> and ( <ðŸŽ“Universities/MIT/2.005 Thermal,Fluids Engineering I> , <ðŸŽ“Universities/MIT/3.012 Fundamentals of Materials Science> , <ðŸŽ“Universities/MIT/5.60 Thermodynamics and Kinetics> , or <ðŸŽ“Universities/MIT/2.772J Thermodynamics of Biomolecular Systems> )) or permission of instructor"
coreq: "None."
---

catalog [10.441[J]](http://student.mit.edu/catalog/m10a.html#10.441), [7.37[J]](http://student.mit.edu/catalog/m7a.html#7.37), [20.361[J]](http://student.mit.edu/catalog/m20a.html#20.361)

<span style="display: block; padding: 15px; background-color: rgb(100, 100, 100, 0.2);"><font id="m_prereq374_0" style="display: block; font-family: Arial, sans-serif; font-weight: bold; padding: 5px">Prerequisites</font><br><span id="prereq374_0">( [[ðŸŽ“Universities/MIT/7.06 Cell Biology | 7.06]] and ( [[ðŸŽ“Universities/MIT/2.005 Thermal,Fluids Engineering I | 2.005]] , [[ðŸŽ“Universities/MIT/3.012 Fundamentals of Materials Science | 3.012]] , [[ðŸŽ“Universities/MIT/5.60 Thermodynamics and Kinetics | 5.60]] , or [[ðŸŽ“Universities/MIT/2.772J Thermodynamics of Biomolecular Systems | 20.110]] )) or permission of instructor</span></span>
<span style="display: block; padding: 15px; background-color: rgb(100, 100, 100, 0.2);"><font id="m_coreq374_0" style="display: block; font-family: Arial, sans-serif; font-weight: bold; padding: 5px">Corequisites</font><br><span id="coreq374_0">None.</span></span>

<font style="">Description:</font>
<font style="color: grey; font-size: 0.8rem;">Covers biological and bioengineering principles underlying the development and therapeutic use of recombinant proteins and stem cells; glycoengineering of recombinant proteins; normal and pathological signaling by growth factors and their receptors; receptor trafficking; monoclonal antibodies as therapeutics; protein pharmacology and delivery; stem cell-derived tissues as therapeutics; RNA therapeutics; combinatorial protein engineering; and new antitumor drugs.</font>



---

<< HELLO, WORLD >>
